Cargando…
GSK-3β, a double-edged sword in Nrf2 regulation: Implications for neurological dysfunction and disease
In the past decade, it has become evident that glycogen synthase kinase 3β (GSK-3β) modulates the nuclear factor erythroid 2-related factor 2 (Nrf2) oxidative stress response. GSK-3β functions as an inhibitor, both directly in the activation and indirectly in the post-induction of Nrf2. The incidenc...
Autores principales: | Culbreth, Megan, Aschner, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
F1000 Research Limited
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6053695/ https://www.ncbi.nlm.nih.gov/pubmed/30079246 http://dx.doi.org/10.12688/f1000research.15239.1 |
Ejemplares similares
-
Nrf2 in cancers: A double‐edged sword
por: Wu, Shijia, et al.
Publicado: (2019) -
Double-edged sword.
Publicado: (1994) -
A Double-edged Sword: Uric Acid and Neurological Disorders
por: Fang, Pu, et al.
Publicado: (2013) -
Autophagic dysfunction of β cell dysfunction in type 2 diabetes, a double-edged sword
por: Yao, Ding, et al.
Publicado: (2020) -
The double-edged sword of evolution
por: Kruzel-Davila, Etty, et al.
Publicado: (2017)